NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
about
Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort studyCancer biomarkers: are we ready for the prime time?NMP22: Does it have a predictive potential for recurrence and progression in non-muscle-invasive bladder cancer?The contemporary role and impact of urine-based biomarkers in bladder cancer.
P2860
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
@en
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients.
@nl
type
label
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
@en
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients.
@nl
prefLabel
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
@en
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients.
@nl
P2093
P2860
P1476
NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients
@en
P2093
Hassan Razvi
Jonathan I Izawa
Joseph L Chin
Stephen Pautler
P2860
P304
P577
2009-12-01T00:00:00Z